VOLUME 34: NO. 12 DECEMBER 2007

Editorials

Longterm Treatment Benefits Are Best Reflected by Patient Reported Outcomes

C.V. Strand, B. Crawford .........2317 →RELATED ARTICLE

Physician... Attorney of the Poor

R. Madhok, N. Alcorn, H.A. Capell .........2320 →RELATED ARTICLE

Venous Thromboembolism in Wegener's Granulomatosis

P. Lamprecht, K. Holl-Ulrich, S. Wieczorek .........2323 →RELATED ARTICLE

Articles

Requirement of MTX in Combination with Anti-TNF-α Therapy for Adequate Suppression of Osteoclastogenesis in RA
   
H. Matsuno, K. Yoshida, A. Ochiai, M. Okamoto .........2326

Effectiveness, Predictive Response Factors, and Safety of Anti-TNF Therapies in Anti-TNF-Naive RA
   
A. Fernández-Nebro, M.V. Irigoyen, I. Ureña, et al .........2334

Improvement and Longterm Maintenance of Quality of Life During Treatment with Adalimumab in Severe RA
   
T. Mittendorf, B. Dietz, R. Sterz, H. Kupper, M.A. Cifaldi, J-M. von der Schulenburg .........2343 →RELATED ARTICLE

Outcome of Early Monoarthritis: A Followup Study
   
A. Binard, S. Alassane, V. Devauchelle-Pensec, et al .........2351

mRNA Expression of Podocyte-Associated Molecules in Urinary Sediment of Patients with Lupus Nephritis
   
G. Wang, F.M-M. Lai, L-S. Tam, et al .........2358

Evaluation of Immunogenicity of the T Cell Costimulation Modulator Abatacept in Patients Treated for RA
   
H.G. Haggerty, M.A. Abbott, T.P. Reilly, et al .........2365

The Italian Registry of Aggressive Rheumatoid Arthritis — the GIARA Project
   
A. Marchesoni, M. Govoni, G. Valentini, et al .........2374

DAS-28 Values Differ Considerably Depending on Patient's Pain Perception and Sex
   
B.F. Leeb, P.M. Haindl, A. Maktari, T. Nothnagl, B. Rintelen .........2382

Increased Augmentation Index in RA and Its Relationship to Coronary Artery Atherosclerosis
   
I. Avalos, C.P. Chung, A. Oeser, et al .........2388

Significant Association of Insertion/Deletion Polymorphism of the ACE Gene with RA
   
S.S. Uppal, M.Z. Haider, S.J. Hayat, M. Abraham, J. Sukumaran, G.S. Dhaunsi .........2395

Initiation of DMARD Therapy in Minority and Disadvantaged Patients with RA
   
M.E. Suarez-Almazor, J.P. Berrios-Rivera, V. Cox, N.M. Janssen, D.M. Marcus,
S. Sessoms .........2400 →RELATED ARTICLE

Association of ACE Gene Polymorphism with Genetic Susceptibility to SLE in Chinese Populations: A Family-based Association Study
   
J. Xu, Y. Wang, F. Pan, et al .........2408

The CD40/CD40 Ligand System in the Skin of Patients with Subacute Cutaneous Lupus Erythematosus
   
M. Caproni, D. Torchia, E. Antiga, et al .........2412

Sildenafil for Pulmonary Arterial Hypertension Associated with Connective Tissue Disease
   
D.B. Badesch, N.S. Hill, G. Burgess, et al, on behalf of the SUPER Study Group .........2417

Natural History of Ischemic Digital Ulcers in SSc: Single-Center Retrospective Longitudinal Study
   
E. Hachulla, P. Clerson, D. Launay, et al .........2423

Cardiac MRI Detects Subclinical Right Ventricular Impairment in SSc
   
G.P. Bezante, D. Rollando, M. Sessarego, et al .........2431

T Regulatory Cells Are Markedly Diminished in Diseased Salivary Glands of Patients with Primary SS
   
X. Li, X. Li, L. Qian, et al .........2438

The Frequency of aCL and Genetic Mutations Associated with Hypercoagulability Among Patients with Wegener's Granulomatosis with and without History of a Thrombotic Event
   
J.K. Sebastian, B. Voetsch, J.H. Stone, et al, for the Wegener's Granulomatosis Etanercept Trial Research Group .........2446 →RELATED ARTICLE

Propylthiouracil-Associated ANCA-Positive Vasculitis: Retrospective Study of 19 Cases
   
Y-X. Chen, H-J. Yu, L-Y. Ni, et al .........2451

Retinol (Vitamin A) and Retinol-Binding Protein Levels Are Decreased in AS: Clinical and Genetic Analysis
   
F.D. O'Shea, F.W.L. Tsui, B. Chiu, H.W. Tsui, M. Yazdanpanah, R.D. Inman .........2457

Prevalence of Ossification of Posterior Longitudinal Ligament in Patients with AS
   
T-J. Kim, T-H. Kim, J-B. Jun, K-B. Joo, W-S. Uhm .........2460

Relationship Between Spinal Mobility and Radiographic Damage in AS and Psoriatic Spondylitis: A Comparative Analysis
   
V. Chandran, F.D. O'Shea, C.T. Schentag, R.D. Inman, D.D. Gladman .........2463

Prevalence and Cost of MSK Disorders: A Population-based, Public Hospital System Healthcare Consumption Approach
   
R.H. Osborne, M. Nikpour, L. Busija, V. Sundararajan, I.P. Wicks .........2466

Quality of Reporting of Randomized Clinical Trials in Abstracts of the 2005 Annual Meeting of the American College of Rheumatology
   
C.L. Hill, R. Buchbinder, R. Osborne .........2476

Pediatric Rheumatology

Etanercept Treatment Improves Longitudinal Growth in Prepubertal Children with JIA
   
P. Fernandez Vojvodich, J.B. Hansen, U. Andersson, L. Sävendahl, S. Hagelberg .........2481

Insomnia and Quality of Life in Children Referred for Limb Pain
   
M.M. LaPlant, B.S. Adams, H.M. Haftel, R.D. Chervin .........2486

Does Red-Man Reaction Stimulate MAS in Children with Systemic JIA?
   
S. Olgar, T. Ertugrul, O. Devecioglu, K. Nisli, R.E. Omeroglu .........2491

Case Report

Sarcoidosis-like Reaction Related to P. acnes and Immune Restoration Syndrome in HIV Infection
   
K. El Karoui, F. Lanternier, A. Brunet, P. Blanche, L. Guillevin .........2495

Images in Rheumatology

Whole-body MRI Evaluation of Widespread Inflammatory Lesions in a Patient with AS Before and After 1-Year Treatment with Infliximab
 
H. Appel, K-G.A. Hermann, C.E. Althoff, M. Rudwaleit, J. Sieper .........2497

Chronic Recurrent Multifocal Osteomyelitis
 
T. Hoffmann, D. Finger .........2499

Letters

"Pseudospondylitis" Caused by Rupture of an Aortic Aneurysm
 
A. Amouzougan, T. Zénone, M. Couret, et al .........2501

SLE in a Patient Treated with Etanercept for Polyarticular JRA
 
S. Bout-Tabaku, R. Rivas-Chacon, R. Restrepo .........2503

CNS Involvement in Blau Syndrome: A New Feature of the Syndrome?
 
A. Emami Nia, M. Nabavi, M. Mousavi Nasab, S. Kashef .........2504

Diagnosis of Muckle-Wells Syndrome — 33 Years Later
 
K.H. Fye, D.H. Siegel, M.K. Connolly .........2505

Corrections

New-onset Psoriatic Palmoplantaris Pustulosis Following Infliximab Therapy: A Class Effect?
 
C.H. Roux, O. Brocq, N. Leccia, et al .........2506

Development of Draft Validation Criteria for a Soluble Biomarker To Be Regarded as a Valid Biomarker Reflecting Structural Damage Endpoints in Rheumatoid Arthritis and Spondyloarthritis Clinical Trials
 
W.P. Maksymowych, R. Landewé, M. Boers, et al .........2506

T Cells Against the Pathogenic and Protective Epitopes of HSP65 Are Crossreactive and Display Functional Similarity: Novel Aspect of Regulation of Autoimmune Arthritis
 
M. Durai, H.R. Kim, K. Bala, K.D. Moudgil .........2506

Meetings in Rheumatology